Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor

Laboratory Investigation

Volumn 91, Issue 7, 2011, Pages 1007-1017

  Huang, Li ^a,b,c   Ramirez, Jonathan C ^a,d   Frampton, Gabriel A ^a   Golden, Lessie E ^a,d   Quinn, Matthew A ^a,b   Pae, Hae Yong ^a   Horvat, Darijana ^a   Liang, Li Jian ^c   Demorrow, Sharon ^a,b,d  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b Digestive Disease Research Center   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

^d SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

cannabinoids; Fas; Ga12 G protein; JNK; lipid rafts

Indexed keywords

ANANDAMIDE; BETA METHYLCYCLODEXTRIN; CANNABINOID RECEPTOR AGONIST; CYCLODEXTRIN; FAS ANTIGEN; FILLIPIN 3; G PROTEIN COUPLED RECEPTOR; JANUS KINASE; MACROLIDE; O 1602; PROTEIN COUPLED RECEPTOR 55; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BILE DUCT CARCINOMA; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIPID RAFT; LIVER BIOPSY; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ARACHIDONIC ACIDS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; ENDOCANNABINOIDS; HUMANS; MICE; MICE, NUDE; POLYUNSATURATED ALKAMIDES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 79959724636     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.62     Document Type: Article

References (49)

1. Blechacz BR, Gores GJ. Cholangiocarcinoma. Clin Liver Dis 2008;12: 131-150, ix. (Pubitemid 351163138)
2. Sirica AE. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 2005;41:5-15. (Pubitemid 40066375)
3. Bisogno T, Ligresti A, Di Marzo V. The endocannabinoid signalling system: biochemical aspects. Pharmacol Biochem Behav 2005;81: 224-238. (Pubitemid 40812404)
4. Devane WA, Dysarz III FA, Johnson MR, et al. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988;34:605-613. (Pubitemid 19007296)
5. Hinz B, Ramer R, Eichele K, et al. R(+)-methanandamide-induced cyclooxygenase-2 expression in H4 human neuroglioma cells: possible involvement of membrane lipid rafts. Biochem Biophys Res Commun 2004;324:621-626. (Pubitemid 39345561)
6. Siegmund SV, Uchinami H, Osawa Y, et al. Anandamide induces necrosis in primary hepatic stellate cells. Hepatology 2005;41: 1085-1095. (Pubitemid 40593916)
7. Mimeault M, Pommery N, Wattez N, et al. Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. Prostate 2003;56:1-12. (Pubitemid 36613150)
8. Lauckner JE, Jensen JB, Chen HY, et al. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci USA 2008;105:2699-2704. (Pubitemid 351520576)
9. Ryberg E, Larsson N, Sjogren S, et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 2007;152:1092-1101. (Pubitemid 350166046)
10. Johns DG, Behm DJ, Walker DJ, et al. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br J Pharmacol 2007;152:825-831. (Pubitemid 350034974)
11. Collins LR, Minden A, Karin M, et al. Galpha12 stimulates c-Jun NH2- terminal kinase through the small G proteins Ras and Rac. J Biol Chem 1996;271:17349-17353. (Pubitemid 26244295)
12. DeMorrow S, Glaser S, Francis H, et al. Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of fas and fas ligand to lipid rafts. J Biol Chem 2007;282:13098-13113. (Pubitemid 47100640)
13. Coufal M, Invernizzi P, Gaudio E, et al. Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma. Int J Cancer 2010;126:2112-2122.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) method. Methods 2001;25:402-408. (Pubitemid 34164012)
15. DeMorrow S, Francis H, Gaudio E, et al. The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. Am J Physiol Gastrointest Liver Physiol 2008;295:G1150-G1158.
16. Alpini G, Invernizzi P, Gaudio E, et al. Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res 2008;68:9184-9193.
17. Scheiffele P, Roth MG, Simons K. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J 1997;16:5501-5508. (Pubitemid 27399842)
18. Orlandi PA, Fishman PH. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 1998;141:905-915. (Pubitemid 28243959)
19. Smart EJ, Ying YS, Conrad PA, et al. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J Cell Biol 1994;127:1185-1197. (Pubitemid 24362556)
20. Shin M, Yan C, Boyd D. An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMAinducible 92-kDa type IV collagenase expression. Biochim Biophys Acta 2002;1589:311-316. (Pubitemid 34603302)
21. Frampton GA, Lazcano EA, Li H, et al. Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents. Lab Invest 2010;90:1325-1338.
22. De Petrocellis L, Melck D, Palmisano A, et al. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci USA 1998;95:8375-8380. (Pubitemid 28326120)
23. Ruiz L, Miguel A, Diaz-Laviada I. Delta9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. FEBS Lett 1999;458:400-404. (Pubitemid 29433843)
24. Sanchez C, de Ceballos ML, del Pulgar TG, et al. Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 2001;61:5784-5789. (Pubitemid 32769095)
25. Sanchez C, Galve-Roperh I, Canova C, et al. Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett 1998;436:6-10. (Pubitemid 28454597)
26. Galve-Roperh I, Sanchez C, Cortes ML, et al. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 2000;6:313-319. (Pubitemid 30148624)
27. Frampton G, Coufal M, Li H, et al. Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling. Exp Cell Res 2010;316:1465-1478.
28. Gamerdinger M, Clement AB, Behl C. Effects of sulindac sulfide on the membrane architecture and the activity of gamma-secretase. Neuropharmacology 2008;54:998-1005.
29. Collu GM, Brennan K. Cooperation between Wnt and Notch signalling in human breast cancer. Breast Cancer Res 2007;9:105.
30. Katoh M. Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades. Int J Mol Med 2009;23:763-769.
31. Nakamura T, Tsuchiya K, Watanabe M. Crosstalk between Wnt and Notch signaling in intestinal epithelial cell fate decision. J Gastroenterol 2007;42:705-710. (Pubitemid 47456757)
32. Sharir H, Abood ME. Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther 2010;126:301-313.
33. Brown AJ, Robin Hiley C. Is GPR55 an anandamide receptor? Vitam Horm 2009;81:111-137.
34. Waldeck-Weiermair M, Zoratti C, Osibow K, et al. Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression. J Cell Sci 2008;121(Part 10):1704-1717. (Pubitemid 351911827)
35. Freeman MR, Solomon KR. Cholesterol and prostate cancer. J Cell Biochem 2004;91:54-69.
36. Tugnoli V, Tosi MR. Cholesteryl ester detection in a human urothelial carcinoma. Clin Chim Acta 2005;360:208-210. (Pubitemid 41225416)
37. Tosi MR, Tugnoli V. Cholesteryl esters in malignancy. Clin Chim Acta 2005;359:27-45. (Pubitemid 41121953)
38. Li YC, Park MJ, Ye SK, et al. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol 2006;168:1107-1118; quiz 1404-1105.
39. Mollinedo F, Gajate C. Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy. Future Oncol 2010;6: 811-821.
40. Mollinedo F, Gajate C. Lipid rafts, death receptors and CASMERs: new insights for cancer therapy. Future Oncol 2010;6:491-494.
41. Pineiro R, Maffucci T, Falasca M. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. Oncogene 2011;30:142-152.
42. Andradas C, Caffarel MM, Perez-Gomez E, et al. The orphan G proteincoupled receptor GPR55 promotes cancer cell proliferation via ERK. Oncogene 2011;30:245-252.
43. Ford LA, Roelofs AJ, Anavi-Goffer S, et al. A role for L-alphalysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells. Br J Pharmacol 2010;160:762-771.
44. Muppidi JR, Tschopp J, Siegel RM. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 2004;21:461-465. (Pubitemid 39370502)
45. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-1308. (Pubitemid 28406815)
46. Waheed AA, Jones TL. Hsp90 interactions and acylation target the G protein Galpha 12 but not Galpha 13 to lipid rafts. J Biol Chem 2002;277:32409-32412. (Pubitemid 34984739)
47. Giuliano M, Calvaruso G, Pellerito O, et al. Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway. Int J Mol Med 2006;17:811-819.
48. Nieto-Miguel T, Gajate C, Gonzalez-Camacho F, et al. Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy. Oncogene 2008;27:1779-1787. (Pubitemid 351380270)
49. Chen S, Bawa D, Besshoh S, et al. Association of heat shock proteins and neuronal membrane components with lipid rafts from the rat brain. J Neurosci Res 2005;81:522-529. (Pubitemid 41297389)